Activation of Muscle Enhancers by MyoD and Epigenetic Modifiers

Journal of Cellular Biochemistry

Volumn 115, Issue 11, 2014, Pages 1855-1867

  Blum, Roy ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ChIP seq; MUSCLE ENHANCERS; MyoD; MYOGENESIS; PLACEHOLDERS; SKELETAL MUSCLE; TRANSCRIPTION

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR; ACYLTRANSFERASE; HISTONE METHYLTRANSFERASE; MEDIATOR COMPLEX; METHYLTRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOD PROTEIN; MYOGENIN; PHOSPHATIDYLINOSITOL 3 KINASE; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN C JUN; RNA POLYMERASE II; TRANSCRIPTION FACTOR; UNTRANSLATED RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; CHROMATIN; ENHANCER REGION; ENZYME ACTIVATION; ENZYME MECHANISM; ENZYME MODIFICATION; EPIGENETICS; GENE EXPRESSION; GENE MAPPING; GENETIC ASSOCIATION; HISTONE MODIFICATION; HUMAN; MOLECULAR DOCKING; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; VERTEBRATE; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; METABOLISM;

ANIMALS; CELL DIFFERENTIATION; ENHANCER ELEMENTS, GENETIC; EPIGENESIS, GENETIC; EPIGENOMICS; GENE EXPRESSION REGULATION; HUMANS; MYOBLASTS; MYOD PROTEIN;

EID: 84941133344     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24854     Document Type: Article

References (133)

1. Arnold CD, Gerlach D, Stelzer C, Boryn LM, Rath M, Stark A,. 2013. Genome-wide quantitative enhancer activity maps identified by STARR-seq. Science 339: 1074-1077.
2. Asp P, Blum R, Vethantham V, Parisi F, Micsinai M, Cheng J, Bowman C, Kluger Y, Dynlacht BD,. 2011. Genome-wide remodeling of the epigenetic landscape during myogenic differentiation. Proc Natl Acad Sci USA 108: E149-E158.
3. Banerji J, Olson L, Schaffner W,. 1983. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 33: 729-740.
4. Banerji J, Rusconi S, Schaffner W,. 1981. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell 27: 299-308.
5. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K,. 2007. High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837.
6. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL,. 2002. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157: 137-148.
7. Bengal E, Ransone L, Scharfmann R, Dwarki VJ, Tapscott SJ, Weintraub H, Verma IM,. 1992. Functional antagonism between c-Jun and MyoD proteins: A direct physical association. Cell 68: 507-519.
8. Bergsland M, Ramskold D, Zaouter C, Klum S, Sandberg R, Muhr J,. 2011. Sequentially acting Sox transcription factors in neural lineage development. Genes Dev 25: 2453-2464.
9. Berkes CA, Bergstrom DA, Penn BH, Seaver KJ, Knoepfler PS, Tapscott SJ,. 2004. Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential. Mol Cell 14: 465-477.
10. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES,. 2006. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326.
11. Blais A, Tsikitis M, Acosta-Alvear D, Sharan R, Kluger Y, Dynlacht BD,. 2005. An initial blueprint for myogenic differentiation. Genes Dev 19: 553-569.
12. Blum R, Vethantham V, Bowman C, Rudnicki M, Dynlacht BD,. 2012. Genome-wide identification of enhancers in skeletal muscle: The role of MyoD1. Genes Dev 26: 2763-2779.
13. Bober E, Franz T, Arnold HH, Gruss P, Tremblay P,. 1994. Pax-3 is required for the development of limb muscles: A possible role for the migration of dermomyotomal muscle progenitor cells. Development 120: 603-612.
14. Bogdanovic O, Fernandez-Minan A, Tena JJ, de la Calle-Mustienes E, Hidalgo C, van Kruysbergen I, van Heeringen SJ, Veenstra GJ, Gomez-Skarmeta JL,. 2012. Dynamics of enhancer chromatin signatures mark the transition from pluripotency to cell specification during embryogenesis. Genome Res 22: 2043-2053.
15. Bonasio R,. 2014. The role of chromatin and epigenetics in the polyphenisms of ant castes. Brief Funct Genomics 13: 235-245.
16. Bonn S, Zinzen RP, Girardot C, Gustafson EH, Perez-Gonzalez A, Delhomme N, Ghavi-Helm Y, Wilczynski B, Riddell A, Furlong EE,. 2012. Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development. Nat Genet 44: 148-156.
17. Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, Weng Z, Furey TS, Crawford GE,. 2008. High-resolution mapping and characterization of open chromatin across the genome. Cell 132: 311-322.
18. Buckingham M, Rigby PW,. 2014. Gene regulatory networks and transcriptional mechanisms that control myogenesis. Dev Cell 28: 225-238.
19. Bulger M, Groudine M,. 2011. Functional and mechanistic diversity of distal transcription enhancers. Cell 144: 327-339.
20. Calo E, Wysocka J,. 2013. Modification of enhancer chromatin: What, how, and why? Mol Cell 49: 825-837.
21. Cao Y, Kumar RM, Penn BH, Berkes CA, Kooperberg C, Boyer LA, Young RA, Tapscott SJ,. 2006. Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters. EMBO J 25: 502-511.
22. Cao Y, Yao Z, Sarkar D, Lawrence M, Sanchez GJ, Parker MH, MacQuarrie KL, Davison J, Morgan MT, Ruzzo WL, Gentleman RC, Tapscott SJ,. 2010. Genome-wide MyoD binding in skeletal muscle cells: A potential for broad cellular reprogramming. Dev Cell 18: 662-674.
23. Caretti G, Di Padova M, Micales B, Lyons GE, Sartorelli V,. 2004. The polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev 18: 2627-2638.
24. Carvajal JJ, Keith A, Rigby PW,. 2008. Global transcriptional regulation of the locus encoding the skeletal muscle determination genes Mrf4 and Myf5. Genes Dev 22: 265-276.
25. Charge SB, Rudnicki MA,. 2004. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84: 209-238.
26. Cheng J, Blum R, Bowman C, Hu D, Shilatifard A, Shen S, Dynlacht BD,. 2014. A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers. Mol Cell 53: 979-992.
27. Chepelev I, Wei G, Wangsa D, Tang Q, Zhao K,. 2012. Characterization of genome-wide enhancer-promoter interactions reveals co-expression of interacting genes and modes of higher order chromatin organization. Cell Res 22: 490-503.
28. Crawford GE, Holt IE, Whittle J, Webb BD, Tai D, Davis S, Margulies EH, Chen Y, Bernat JA, Ginsburg D, Zhou D, Luo S, Vasicek TJ, Daly MJ, Wolfsberg TG, Collins FS,. 2006. Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res 16: 123-131.
29. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA, Boyer LA, Young RA, Jaenisch R,. 2010. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci USA 107: 21931-21936.
30. Crist CG, Montarras D, Buckingham M,. 2012. Muscle satellite cells are primed for myogenesis but maintain quiescence with sequestration of Myf5 mRNA targeted by microRNA-31 in mRNP granules. Cell Stem Cell 11: 118-126.
31. Davis RL, Weintraub H, Lassar AB,. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51: 987-1000.
32. de la Serna IL, Ohkawa Y, Berkes CA, Bergstrom DA, Dacwag CS, Tapscott SJ, Imbalzano AN,. 2005. MyoD targets chromatin remodeling complexes to the myogenin locus prior to forming a stable DNA-bound complex. Mol Cell Biol 25: 3997-4009.
33. De Santa F, Barozzi I, Mietton F, Ghisletti S, Polletti S, Tusi BK, Muller H, Ragoussis J, Wei CL, Natoli G,. 2010. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol 8: e1000384.
34. Dilworth FJ, Seaver KJ, Fishburn AL, Htet SL, Tapscott SJ,. 2004. In vitro transcription system delineates the distinct roles of the coactivators pCAF and p300 during MyoD/E47-dependent transactivation. Proc Natl Acad Sci USA 101: 11593-11598.
35. Ebisuya M, Yamamoto T, Nakajima M, Nishida E,. 2008. Ripples from neighbouring transcription. Nat Cell Biol 10: 1106-1113.
36. Farajollahi S, Maas S,. 2010. Molecular diversity through RNA editing: A balancing act. Trends Genet 26: 221-230.
37. Forcales SV, Albini S, Giordani L, Malecova B, Cignolo L, Chernov A, Coutinho P, Saccone V, Consalvi S, Williams R, Wang K, Wu Z, Baranovskaya S, Miller A, Dilworth FJ, Puri PL,. 2012. Signal-dependent incorporation of MyoD-BAF60c into Brg1-based SWI/SNF chromatin-remodelling complex. EMBO J 31: 301-316.
38. Gerber AN, Klesert TR, Bergstrom DA, Tapscott SJ,. 1997. Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: A mechanism for lineage determination in myogenesis. Genes Dev 11: 436-450.
39. Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, Venturini E, Gregory L, Lonie L, Chew A, Wei CL, Ragoussis J, Natoli G,. 2010. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32: 317-328.
40. Giresi PG, Kim J, McDaniell RM, Iyer VR, Lieb JD,. 2007. FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res 17: 877-885.
41. Goldhamer DJ, Brunk BP, Faerman A, King A, Shani M, Emerson CP, Jr,. 1995. Embryonic activation of the myoD gene is regulated by a highly conserved distal control element. Development 121: 637-649.
42. Heimberg AM, Sempere LF, Moy VN, Donoghue PC, Peterson KJ,. 2008. MicroRNAs and the advent of vertebrate morphological complexity. Proc Natl Acad Sci USA 105: 2946-2950.
43. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, Wang W, Weng Z, Green RD, Crawford GE, Ren B,. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39: 311-318.
44. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW, Ching KA, Antosiewicz-Bourget JE, Liu H, Zhang X, Green RD, Lobanenkov VV, Stewart R, Thomson JA, Crawford GE, Kellis M, Ren B,. 2009. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459: 108-112.
45. Herz HM, Mohan M, Garruss AS, Liang K, Takahashi YH, Mickey K, Voets O, Verrijzer CP, Shilatifard A,. 2012. Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3/Mll4. Genes Dev 26: 2604-2620.
46. Hu D, Gao X, Morgan MA, Herz HM, Smith ER, Shilatifard A,. 2013. The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers. Mol Cell Biol 33: 4745-4754.
47. Jang YN, Lee IJ, Park MC, Baik EJ,. 2011. Role of JAK3 in myogenic differentiation. Cell Signal 24: 742-749.
48. Jeong KW, Kim K, Situ AJ, Ulmer TS, An W, Stallcup MR,. 2011. Recognition of enhancer element-specific histone methylation by TIP60 in transcriptional activation. Nat Struct Mol Biol 18: 1358-1365.
49. Jin Q, Yu LR, Wang L, Zhang Z, Kasper LH, Lee JE, Wang C, Brindle PK, Dent SY, Ge K,. 2011. Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J 30: 249-262.
50. Johnson JE, Wold BJ, Hauschka SD,. 1989. Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol Cell Biol 9: 3393-3399.
51. Juan AH, Kumar RM, Marx JG, Young RA, Sartorelli V,. 2009. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 36: 61-74.
52. Kaikkonen MU, Spann NJ, Heinz S, Romanoski CE, Allison KA, Stender JD, Chun HB, Tough DF, Prinjha RK, Benner C, Glass CK,. 2013. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol Cell 51: 310-325.
53. Karmodiya K, Krebs AR, Oulad-Abdelghani M, Kimura H, Tora L,. 2012. H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells. BMC Genomics 13: 424.
54. Kawabe Y, Wang YX, McKinnell IW, Bedford MT, Rudnicki MA,. 2012. Carm1 regulates Pax7 transcriptional activity through MLL1/2 recruitment during asymmetric satellite stem cell divisions. Cell Stem Cell 11: 333-345.
55. Kellum R, Schedl P,. 1992. A group of scs elements function as domain boundaries in an enhancer-blocking assay. Mol Cell Biol 12: 2424-2431.
56. Kim HK, Lee YS, Sivaprasad U, Malhotra A, Dutta A,. 2006. Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 174: 677-687.
57. Kim E, Magen A, Ast G,. 2007. Different levels of alternative splicing among eukaryotes. Nucleic Acids Res 35: 125-131.
58. Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, Harmin DA, Laptewicz M, Barbara-Haley K, Kuersten S, Markenscoff-Papadimitriou E, Kuhl D, Bito H, Worley PF, Kreiman G, Greenberg ME,. 2010. Widespread transcription at neuronal activity-regulated enhancers. Nature 465: 182-187.
59. Knoepfler PS, Bergstrom DA, Uetsuki T, Dac-Korytko I, Sun YH, Wright WE, Tapscott SJ, Kamps MP,. 1999. A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1. Nucleic Acids Res 27: 3752-3761.
60. Koch CM, Andrews RM, Flicek P, Dillon SC, Karaoz U, Clelland GK, Wilcox S, Beare DM, Fowler JC, Couttet P, James KD, Lefebvre GC, Bruce AW, Dovey OM, Ellis PD, Dhami P, Langford CF, Weng Z, Birney E, Carter NP, Vetrie D, Dunham I,. 2007. The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res 17: 691-707.
61. Krebs AR, Karmodiya K, Lindahl-Allen M, Struhl K, Tora L,. 2011. SAGA and ATAC histone acetyl transferase complexes regulate distinct sets of genes and ATAC defines a class of p300-independent enhancers. Mol Cell 44: 410-423.
62. Lai F, Orom UA, Cesaroni M, Beringer M, Taatjes DJ, Blobel GA, Shiekhattar R,. 2013. Activating RNAs associate with mediator to enhance chromatin architecture and transcription. Nature 494: 497-501.
63. Lawlor MA, Rotwein P,. 2000. Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21. Mol Cell Biol 20: 8983-8995.
64. Lee W, Haslinger A, Karin M, Tjian R,. 1987. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature 325: 368-372.
65. Lee JE, Wang C, Xu S, Cho YW, Wang L, Feng X, Baldridge A, Sartorelli V, Zhuang L, Peng W, Ge K,. 2013. H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation. Elife 2: e01503.
66. Liu Y, Chakroun I, Yang D, Horner E, Liang J, Aziz A, Chu A, De Repentigny Y, Dilworth FJ, Kothary R, Blais A,. 2013. Six1 regulates MyoD expression in adult muscle progenitor cells. PLoS ONE 8: e67762.
67. Lluis F, Ballestar E, Suelves M, Esteller M, Munoz-Canoves P,. 2005. E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription. EMBO J 24: 974-984.
68. Lu J, Webb R, Richardson JA, Olson EN,. 1999. MyoR: A muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD. Proc Natl Acad Sci USA 96: 552-557.
69. Lu J, McKinsey TA, Nicol RL, Olson EN,. 2000a. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci USA 97: 4070-4075.
70. Lu J, McKinsey TA, Zhang CL, Olson EN,. 2000b. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell 6: 233-244.
71. Ludolph DC, Konieczny SF,. 1995. Transcription factor families: Muscling in on the myogenic program. FASEB J 9: 1595-1604.
72. Macquarrie KL, Yao Z, Young JM, Cao Y, Tapscott SJ,. 2012. MiR-206 integrates multiple components of differentiation pathways to control the transition from growth to differentiation in rhabdomyosarcoma cells. Skelet Muscle 2: 7.
73. Mal A, Sturniolo M, Schiltz RL, Ghosh MK, Harter ML,. 2001. A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: Inhibition of the myogenic program. EMBO J 20: 1739-1753.
74. Maves L, Waskiewicz AJ, Paul B, Cao Y, Tyler A, Moens CB, Tapscott SJ,. 2007. Pbx homeodomain proteins direct Myod activity to promote fast-muscle differentiation. Development 134: 3371-3382.
75. May D, Blow MJ, Kaplan T, McCulley DJ, Jensen BC, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, Wright C, Afzal V, Simpson PC, Rubin EM, Black BL, Bristow J, Pennacchio LA, Visel A,. 2012. Large-scale discovery of enhancers from human heart tissue. Nat Genet 44: 89-93.
76. McKinnell IW, Ishibashi J, Le Grand F, Punch VG, Addicks GC, Greenblatt JF, Dilworth FJ, Rudnicki MA,. 2008. Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex. Nat Cell Biol 10: 77-84.
77. McKinsey TA, Zhang CL, Lu J, Olson EN,. 2000. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408: 106-111.
78. Mikkelsen TS, Xu Z, Zhang X, Wang L, Gimble JM, Lander ES, Rosen ED,. 2010. Comparative epigenomic analysis of murine and human adipogenesis. Cell 143: 156-169.
79. Moncaut N, Cross JW, Siligan C, Keith A, Taylor K, Rigby PW, Carvajal JJ,. 2012. Musculin and TCF21 coordinate the maintenance of myogenic regulatory factor expression levels during mouse craniofacial development. Development 139: 958-967.
80. Moncaut N, Rigby PW, Carvajal JJ,. 2013. Dial M(RF) for myogenesis. FEBS J 280: 3980-3990.
81. Moreau P, Hen R, Wasylyk B, Everett R, Gaub MP, Chambon P,. 1981. The SV40 72 base repair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants. Nucleic Acids Res 9: 6047-6068.
82. Murtha M, Tokcaer-Keskin Z, Tang Z, Strino F, Chen X, Wang Y, Xi X, Basilico C, Brown S, Bonneau R, Kluger Y, Dailey L,. 2014. FIREWACh: High-throughput functional detection of transcriptional regulatory modules in mammalian cells. Nat Methods 11: 559-565.
83. Nabeshima Y, Hanaoka K, Hayasaka M, Esumi E, Li S, Nonaka I, Nabeshima Y,. 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364: 532-535.
84. Narlikar L, Sakabe NJ, Blanski AA, Arimura FE, Westlund JM, Nobrega MA, Ovcharenko I,. 2010. Genome-wide discovery of human heart enhancers. Genome Res 20: 381-392.
85. Natoli G, Andrau JC,. 2012. Noncoding transcription at enhancers: general principles and functional models. Annu Rev Genet 46: 1-19.
86. Ong CT, Corces VG,. 2011. Enhancer function: New insights into the regulation of tissue-specific gene expression. Nat Rev Genet 12: 283-293.
87. Ostrovsky O, Bengal E, Aronheim A,. 2002. Induction of terminal differentiation by the c-Jun dimerization protein JDP2 in C2 myoblasts and rhabdomyosarcoma cells. J Biol Chem 277: 40043-40054.
88. Ostuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, Bonifacio S, Curina A, Prosperini E, Ghisletti S, Natoli G,. 2013. Latent enhancers activated by stimulation in differentiated cells. Cell 152: 157-171.
89. Oustanina S, Hause G, Braun T,. 2004. Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification. EMBO J 23: 3430-3439.
90. Pasini D, Malatesta M, Jung HR, Walfridsson J, Willer A, Olsson L, Skotte J, Wutz A, Porse B, Jensen ON, Helin K,. 2010. Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res 38: 4958-4969.
91. Prabhakar S, Poulin F, Shoukry M, Afzal V, Rubin EM, Couronne O, Pennacchio LA,. 2006. Close sequence comparisons are sufficient to identify human cis-regulatory elements. Genome Res 16: 855-863.
92. Puri PL, Sartorelli V, Yang XJ, Hamamori Y, Ogryzko VV, Howard BH, Kedes L, Wang JY, Graessmann A, Nakatani Y, Levrero M,. 1997. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell 1: 35-45.
93. Puri PL, Wu Z, Zhang P, Wood LD, Bhakta KS, Han J, Feramisco JR, Karin M, Wang JY,. 2000. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev 14: 574-584.
94. Puri PL, Iezzi S, Stiegler P, Chen TT, Schiltz RL, Muscat GE, Giordano A, Kedes L, Wang JY, Sartorelli V,. 2001. Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol Cell 8: 885-897.
95. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J,. 2011. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470: 279-283.
96. Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, Zeng T, Euskirchen G, Bernier B, Varhol R, Delaney A, Thiessen N, Griffith OL, He A, Marra M, Snyder M, Jones S,. 2007. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods 4: 651-657.
97. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP,. 2011. A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell 146: 353-358.
98. Sartorelli V, Puri PL, Hamamori Y, Ogryzko V, Chung G, Nakatani Y, Wang JY, Kedes L,. 1999. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol Cell 4: 725-734.
99. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA,. 2000. Pax7 is required for the specification of myogenic satellite cells. Cell 102: 777-786.
100. Sekiya T, Zaret KS,. 2007. Repression by Groucho/TLE/Grg proteins: Genomic site recruitment generates compacted chromatin in vitro and impairs activator binding in vivo. Mol Cell 28: 291-303.
101. Serandour AA, Avner S, Percevault F, Demay F, Bizot M, Lucchetti-Miganeh C, Barloy-Hubler F, Brown M, Lupien M, Metivier R, Salbert G, Eeckhoute J,. 2011. Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Res 21: 555-565.
102. Shlyueva D, Stampfel G, Stark A,. 2014. Transcriptional enhancers: from properties to genome-wide predictions. Nat Rev Genet 15: 272-286.
103. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, Clawson H, Spieth J, Hillier LW, Richards S, Weinstock GM, Wilson RK, Gibbs RA, Kent WJ, Miller W, Haussler D,. 2005. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 15: 1034-1050.
104. Simon JA, Kingston RE,. 2009. Mechanisms of polycomb gene silencing: Knowns and unknowns. Nat Rev Mol Cell Biol 10: 697-708.
105. Simone C, Forcales SV, Hill DA, Imbalzano AN, Latella L, Puri PL,. 2004. P38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat Genet 36: 738-743.
106. Soleimani VD, Punch VG, Kawabe Y, Jones AE, Palidwor GA, Porter CJ, Cross JW, Carvajal JJ, Kockx CE, van IWF Perkins, Rigby PW, Grosveld F, Rudnicki MA,. 2012. Transcriptional dominance of Pax7 in adult myogenesis is due to high-affinity recognition of homeodomain motifs. Dev Cell 22: 1208-1220.
107. Spitz F, Furlong EE,. 2012. Transcription factors: From enhancer binding to developmental control. Nat Rev Genet 13: 613-626.
108. Sun L, Ma K, Wang H, Xiao F, Gao Y, Zhang W, Wang K, Gao X, Ip N, Wu Z,. 2007. JAK1-STAT1-STAT3, a key pathway promoting proliferation and preventing premature differentiation of myoblasts. J Cell Biol 179: 129-138.
109. Tao Y, Neppl RL, Huang ZP, Chen J, Tang RH, Cao R, Zhang Y, Jin SW, Wang DZ,. 2011. The histone methyltransferase Set7/9 promotes myoblast differentiation and myofibril assembly. J Cell Biol 194: 551-565.
110. Tie F, Banerjee R, Stratton CA, Prasad-Sinha J, Stepanik V, Zlobin A, Diaz MO, Scacheri PC, Harte PJ,. 2009. CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing. Development 136: 3131-3141.
111. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L,. 2010. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28: 511-515.
112. Tremblay P, Dietrich S, Mericskay M, Schubert FR, Li Z, Paulin D,. 1998. A crucial role for Pax3 in the development of the hypaxial musculature and the long-range migration of muscle precursors. Dev Biol 203: 49-61.
113. Trenerry MK, Della Gatta, Cameron-Smith PA,. 2011. JAK/STAT signaling and human in vitro myogenesis. BMC Physiol 11: 6.
114. Vahedi G, Takahashi H, Nakayamada S, Sun HW, Sartorelli V, Kanno Y, O'Shea JJ,. 2012. STATs shape the active enhancer landscape of T cell populations. Cell 151: 981-993.
115. Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, Wright C, Chen F, Afzal V, Ren B, Rubin EM, Pennacchio LA,. 2009. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457: 854-858.
116. Visel A, Taher L, Girgis H, May D, Golonzhka O, Hoch RV, McKinsey GL, Pattabiraman K, Silberberg SN, Blow MJ, Hansen DV, Nord AS, Akiyama JA, Holt A, Hosseini R, Phouanenavong S, Plajzer-Frick I, Shoukry M, Afzal V, Kaplan T, Kriegstein AR, Rubin EM, Ovcharenko I, Pennacchio LA, Rubenstein JL,. 2013. A high-resolution enhancer atlas of the developing telencephalon. Cell 152: 895-908.
117. von Scheven G, Bothe I, Ahmed MU, Alvares LE, Dietrich S,. 2006. Protein and genomic organisation of vertebrate MyoR and Capsulin genes and their expression during avian development. Gene Expr Patterns 6: 383-393.
118. Wakabayashi-Takai E, Noguchi S, Ozawa E,. 2001. Identification of myogenesis-dependent transcriptional enhancers in promoter region of mouse gamma-sarcoglycan gene. Eur J Biochem 268: 948-957.
119. Wang X, Blagden C, Fan J, Nowak SJ, Taniuchi I, Littman DR, Burden SJ,. 2005. Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle. Genes Dev 19: 1715-1722.
120. Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS, Croce CM, Guttridge DC,. 2008a. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14: 369-381.
121. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, Cui K, Roh TY, Peng W, Zhang MQ, Zhao K,. 2008b. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40: 897-903.
122. Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, Lassar AB, Miller AD,. 1989. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci USA 86: 5434-5438.
123. Weintraub H, Davis R, Lockshon D, Lassar A,. 1990. MyoD binds cooperatively to two sites in a target enhancer sequence: Occupancy of two sites is required for activation. Proc Natl Acad Sci USA 87: 5623-5627.
124. Wentworth BM, Donoghue M, Engert JC, Berglund EB, Rosenthal N,. 1991. Paired MyoD-binding sites regulate myosin light chain gene expression. Proc Natl Acad Sci USA 88: 1242-1246.
125. Wong CF, Tellam RL,. 2008. MicroRNA-26a targets the histone methyltransferase enhancer of Zeste homolog 2 during myogenesis. J Biol Chem 283: 9836-9843.
126. Wu Z, Woodring PJ, Bhakta KS, Tamura K, Wen F, Feramisco JR, Karin M, Wang JY, Puri PL,. 2000. P38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol 20: 3951-3964.
127. Xiao F, Wang H, Fu X, Li Y, Ma K, Sun L, Gao X, Wu Z,. 2011. Oncostatin M inhibits myoblast differentiation and regulates muscle regeneration. Cell Res 21: 350-364.
128. Xu J, Watts JA, Pope SD, Gadue P, Kamps M, Plath K, Zaret KS, Smale ST,. 2009. Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells. Genes Dev 23: 2824-2838.
129. Yang Z, MacQuarrie KL, Analau E, Tyler AE, Dilworth FJ, Cao Y, Diede SJ, Tapscott SJ,. 2009. MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state. Genes Dev 23: 694-707.
130. Yee SP, Rigby PW,. 1993. The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev 7: 1277-1289.
131. Yuan GC, Liu YJ, Dion MF, Slack MD, Wu LF, Altschuler SJ, Rando OJ,. 2005. Genome-scale identification of nucleosome positions in S. cerevisiae. Science 309: 626-630.
132. Zaret KS, Carroll JS,. 2011. Pioneer transcription factors: establishing competence for gene expression. Genes Dev 25: 2227-2241.
133. Zhao M, New L, Kravchenko VV, Kato Y, Gram H, di Padova F, Olson EN, Ulevitch RJ, Han J,. 1999. Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol 19: 21-30.